Clinical Trial

Intermittent Hypoxia in Persons With Multiple Sclerosis

Recruiting
View on ClinicalTrials.gov →
Summary
This study aims to understand the mechanisms of a novel intervention involving breathing short durations of low levels of oxygen for persons with multiple sclerosis (MS). This intervention with low levels of oxygen is called Acute Intermittent Hypoxia (AIH), the levels of oxygen experienced are similar to breathing the air on a tall mountain, for less than 1 minute at a time. Previous studies have shown that AIH is a safe and effective way to increase strength in persons with MS. Here the investigators aim to look at brain activation and ankle strength before and after AIH to gain a better understanding of how the AIH may improve strength in those persons with MS.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2024-02-22; most recent amendment 2026-03-18.
Status change: Not Yet Recruiting → Recruiting 2024-04-30
Trial Details
NCT Number NCT06276634
Lead Sponsor Shirley Ryan AbilityLab
Collaborators: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Northwestern University
Conditions Multiple Sclerosis, Multiple Sclerosis-Relapsing-Remitting, Multiple Sclerosis, Secondary Progressive
Enrollment 21 participants
Start Date 2024-04-30
Primary Completion 2025-11-03 (estimated)
Study Completion 2027-01 (estimated)
Updated on ClinicalTrials.gov 2026-03-20